脊柱转移瘤手术后生存趋势:20年癌症中心经验
该研究基于一家癌症中心1515例因转移性硬膜外脊髓压迫或肿瘤相关机械不稳定而接受手术的患者,采用Kaplan-Meier法计算术后总生存,并以Cox比例风险模型分析按手术年份的生存趋势。
要点
- 肾癌、乳腺癌、肺癌、结肠癌脊柱转移患者术后生存随手术年份显著改善。
核心结论
- 脊柱转移瘤患者术后生存过去20年有所改善,尤其在肾癌、乳腺癌、肺癌和结肠癌脊柱转移患者中。
- 生存改善提示对接受脊柱转移瘤手术的患者,治疗决策需考虑长期结局。
研究设计与样本
- 回顾性分析一家癌症中心1515例因转移性硬膜外脊髓压迫或肿瘤相关机械不稳定接受手术的患者。
- 采用Kaplan-Meier法计算术后总生存,以Cox比例风险模型分析按手术年份的生存趋势。
主要发现
- 肾癌、乳腺癌、肺癌和结肠癌脊柱转移患者按手术年份生存显著改善,研究期间提高40%-100%。
关键数值与推荐
- 肾癌、乳腺癌、肺癌、结肠癌脊柱转移患者生存改善幅度为研究期间40%-100%。
临床怎么用
- 对肾癌、乳腺癌、肺癌、结肠癌脊柱转移患者手术决策时应重视长期生存可能。
- 同时性与异时性转移的生存差异可供术前评估参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Over the last 2 decades, advances in systemic therapy have increased the expected overall survival for patients with cancer. It is unclear whether the same survival benefit has been conferred to patients requiring surgery for metastatic spinal disease. OBJECTIVE: To examine trends in postoperative survival over a 20-yr period for patients surgically treated for spinal metastatic disease. METHODS: Data were obtained for 1515 patients who underwent surgery for metastatic epidural spinal cord compression or tumor-related mechanical instability. Postoperative overall survival was calculated for all included patients using Kaplan-Meier methodology from date of surgery until death or last follow-up for those who were censored. Trends were analyzed using Cox proportional hazards modeling. RESULTS: Patients with renal, breast, lung, and colon cancers experienced a statistically significant improvement in survival over time based on the year of surgery (40%-100% improvement over the study period), whereas the overall survival trend for the entire cohort did not reach statistical significance (P = .12, median survival 0.71 yr, 95% CI 0.63-0.78). Patients presenting with synchronous metastatic disease had better survival compared to those presenting with metachronous disease (median overall survival: 0.94 vs 0.63 yr, respectively; log-rank P-value = .00001). CONCLUSION: The postoperative survival among patients with spinal metastases has improved over the past 20 yr, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine. The observed survival improvement emphasizes the need for long-term outcome consideration in treatment decisions for patients undergoing surgery for spinal metastatic tumors.
引用
- Rothrock RJ, Barzilai O, Reiner AS, et al. Survival Trends After Surgery for Spinal Metastatic Tumors: 20-Year Cancer Center Experience. Neurosurgery. 2021. PMID: 32970144. doi:10.1093/neuros/nyaa380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。